Ronald Hunt, Director, 10% Owner at Harpoon Therapeutics, Inc. (HARP), bought 892,852 shares at $14.00 ($6.0M) on 2019-02-12, disclosed to the SEC on 2019-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 464,281 | $0 | 0.0% |
| 2 | $14.00 | 214,285 | $3.0M | 50.0% |
| 3 | $14.00 | 214,286 | $3.0M | 50.0% |
| Total | $6.72 avg | 892,852 | $6.0M | 100% |
| Filing → |
| ITRM | BUY | 2018-05-31 | $8.6M | — | Filing → |
| MEIP | SELL | 2014-12-10 | $476K | — | Filing → |
| RLYP | BUY | 2013-11-20 | $2.0M | — | Filing → |